株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

家禽用ワクチンの世界市場 - 成長、動向、予測(2019年~2024年)

Poultry Vaccines Market - Growth, Trends, and Forecast (2019 - 2024)

発行 Mordor Intelligence LLP 商品コード 910283
出版日 ページ情報 英文 113 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=111.33円で換算しております。
Back to Top
家禽用ワクチンの世界市場 - 成長、動向、予測(2019年~2024年) Poultry Vaccines Market - Growth, Trends, and Forecast (2019 - 2024)
出版日: 2019年11月01日 ページ情報: 英文 113 Pages
概要

飼育される家禽の増加、食品の安全性に対する関心の高まり、人獣共通感染症の増加、世界的な食肉需要の拡大、ワクチン製造の新技術などが当市場の主な成長促進要因となっています。

当レポートでは、世界の家禽用ワクチン市場を調査し、市場の概要、疾患・技術・地域別の市場規模の推移と予測、市場の成長要因および阻害要因の分析、競合情勢、主要企業のプロファイルなど、包括的な情報を提供しています。

目次

第1章 イントロダクション

  • 調査成果
  • 調査の前提条件
  • 調査範囲

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 市場力学

  • 市場概況
  • 市場の成長要因
    • 家禽の病気の増加
    • 食品の安全性に対する関心の高まり
    • 人獣共通感染症の発生率の増加
  • 市場の阻害要因
    • 偽造医薬品の使用
    • 動物実験および獣医サービスのコストの増加
  • ファイブフォース分析
    • 買い手の交渉力
    • 供給企業の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係

第5章 市場セグメンテーション

  • 疾患別
    • 気管支炎
    • 鳥インフルエンザ
    • ニューカッスル病
    • マレック病
    • その他
  • 技術別
    • トキソイドワクチン
    • 組換えワクチン
    • 不活化ワクチン
    • 弱毒生ワクチン(LAV)
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋地域
    • 中東・アフリカ
    • 南米

第6章 競合情勢

  • 企業プロファイル
    • AniCon Labor GmbH
    • Animal Science Products Inc.
    • Biovac
    • Boehringer Ingelheim International GmbH
    • ADL BIONATUR SOLUTIONS, S.A.
    • Ceva Animal Health
    • Elanco
    • Intervac (Pvt) Ltd
    • Merck Animal Health
    • Merial
    • Phibro Animal Health Corporation
    • Zoetis Inc

第7章 市場機会および将来動向

目次
Product Code: 57307

Market Overview

The demand for poultry vaccines is majorly driven by the growing poultry headcount and increasing prevalence of zoonotic diseases in poultry. Furthermore, growing consumption of meat globally, initiatives are taken by the government, growing demand for poultry-related food products, latest technologies for manufacturing new vaccines and the increasing poultry healthcare expenditure are the factors that are fueling the growth of the global poultry vaccines market.

Scope of the Report

Vaccines help to prevent any particular disease by boosting the bird's immune system to produce antibodies, which in turn, fight against organisms, especially Salmonella, E. coli, and Mycoplasma gallisepticum (MG), and diseases like Marek's disease, infectious bronchitis (IB), avian rhinotracheitis (ART), Newcastle disease, and infectious bursal disease (Gumboro disease).

Key Market Trends

Avian influenza is Expected to Lead the Market

Avian influenza is a viral disease which is found across all the countries in the world and occurs in birds. The severity of the disease can vary from mild to severe. Avian influenza is transmitted to human beings by direct contact. Disease outbreaks have been reported in countries, such as the United States, Asia, and Europe. The vaccines are approved only if they pass the standards set by the World Organization for Animal Health. The vaccine for the avian influenza is given to imbibe the protection against hemagglutinin (HA) protein. The CDC has given statistics on the spread of avian influenza in the United States. The stats indicate that HPAI H5 viruses were reported in around 21 states in the United States during 2014-2015. Furthermore, the CDC has reported that the mortality for this disease is around 90%-100%. This shows that the disease is associated with a high risk. Hence, the regulatory bodies are now accelerating the process of approval for various vaccines related to veterinary health.

North America is expected to dominate over the Forecast Period

North America is expected to dominate the market over the forecast period, owing to the factors, such as the increase in consumption of poultry-derived products, growing consumer awareness regarding food safety, and increasing incidence of zoonotic diseases associated with poultry. According to the data published by the US department of agriculture (USDA), the per capita consumption of poultry products in 2016 was 107.6 pounds and was increased to 108.6 pounds in 2017. Furthermore, there is an increase in the production of eggs and hen, in shell in the region, as per the statistics published by the UNFAO. In 2015, the country produced 14,639,012 ton of eggs, hen, in shell, which was increased to 14,490,724 ton in 2016. Veterinary Vaccines in the United States is regulated by the Center for Veterinary Biologics (CVB) in the Animal and Plant Health Inspection Service (APHIS). The CVB grants establishment and product license to animal health companies, to manufacture and sell veterinary biologics. In North America advancements in vaccines development include the development of live vector vaccines, non-replicating recombinant antigen vaccines, nucleic acid-mediated vaccines, and live-gene-deleted vaccines.

Competitive Landscape

The market players in the poultry vaccines market are involving in various growth strategies such as collaborations, partnerships, agreements, mergers, and acquisitions in order to enhance the market presence. Key players in the market are Merial, AniCon Labor GmbH, Animal Science Products, Inc., Bio-Vet, Boehringer Ingelheim, Ceva Animal Health, Elanco, Intervac (Pvt) Ltd, Merck & Co., Phibro Animal Health Corporation, Seppic, Venkys, and Zoetis Inc.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

TABLE OF CONTENTs

1. INTRODUCTION

  • 1.1. Study Deliverables
  • 1.2. Study Assumptions
  • 1.3. Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1. Market Overview
  • 4.2. Market Drivers
    • 4.2.1. Increasing Incidences of Poultry Diseases
    • 4.2.2. Widened Focus on Food Safety
    • 4.2.3. Increasing Incidences of Zoonotic Diseases
  • 4.3. Market Restraints
    • 4.3.1. Use of Counterfeit Medicine
    • 4.3.2. Increasing Costs of Animal Testing and Veterinary Services
  • 4.4. Porter's Five Force Analysis
    • 4.4.1. Threat of New Entrants
    • 4.4.2. Bargaining Power of Buyers/Consumers
    • 4.4.3. Bargaining Power of Suppliers
    • 4.4.4. Threat of Substitute Products
    • 4.4.5. Intensity of Competitive Rivalry

5. MARKET SEGMENTATION

  • 5.1. By Disease
    • 5.1.1. Bronchitis
    • 5.1.2. Avian Influenza
    • 5.1.3. Newcastle disease
    • 5.1.4. Marek's Disease
    • 5.1.5. Others
  • 5.2. By Technology
    • 5.2.1. Toxoid Vaccines
    • 5.2.2. Recombinant Vaccines
    • 5.2.3. Inactivated Vaccines
    • 5.2.4. Live Attenuated Vaccines (LAV)
  • 5.3. Geography
    • 5.3.1. North America
      • 5.3.1.1. US
      • 5.3.1.2. Canada
      • 5.3.1.3. Mexico
    • 5.3.2. Europe
      • 5.3.2.1. Germany
      • 5.3.2.2. UK
      • 5.3.2.3. France
      • 5.3.2.4. Italy
      • 5.3.2.5. Spain
      • 5.3.2.6. Rest of Europe
    • 5.3.3. Asia Pacific
      • 5.3.3.1. China
      • 5.3.3.2. Japan
      • 5.3.3.3. India
      • 5.3.3.4. Australia
      • 5.3.3.5. South Korea
      • 5.3.3.6. Rest of Asia-Pacific
    • 5.3.4. Middle East and Africa
      • 5.3.4.1. GCC
      • 5.3.4.2. South Africa
      • 5.3.4.3. Rest of Middle East and Africa
    • 5.3.5. South America
      • 5.3.5.1. Brazil
      • 5.3.5.2. Argentina
      • 5.3.5.3. Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1. Company Profiles
    • 6.1.1. AniCon Labor GmbH
    • 6.1.2. Animal Science Products Inc.
    • 6.1.3. Biovac
    • 6.1.4. Boehringer Ingelheim International GmbH
    • 6.1.5. ADL BIONATUR SOLUTIONS, S.A.
    • 6.1.6. Ceva Animal Health
    • 6.1.7. Elanco
    • 6.1.8. Intervac (Pvt) Ltd
    • 6.1.9. Merck Animal Health
    • 6.1.10. Merial
    • 6.1.11. Phibro Animal Health Corporation
    • 6.1.12. Zoetis Inc

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

Back to Top